Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aditya Sarawgi

Is Insulet Stock Outperforming the Nasdaq?

Acton, Massachusetts-based Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. With a market cap of $16.6 billion, Insulet’s operations span the United States, Canada, Europe, the Middle East, Australia, and internationally.

Companies worth $10 billion or more are generally described as "large-cap stocks," Insulet fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical devices industry. It was the first medical device manufacturer to develop a tubeless insulin delivery system and a mobile app that helps people manage their diabetes remotely.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.